A critical advance in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This essential cancer inhibitor protein is frequently inactivated in several forms of malignancies, leading https://onelifesocial.com/story7418473/nanobodies-restore-tumor-suppressor-p53-a-promising-pathway-for-tumor-management